Learn about Huateng's latest developments, industry news, and research findings
Pigs are becoming an increasingly essential animal model in biomedical research due to their anatomical and physiological similarities to humans. This makes them invaluable for studying human disease, testing medical devices, and developing treatments. In this guide, we will explore why pig models are pivotal in preclinical research, how they are used across various medical fields, and important considerations for researchers utilizing these animal models for medical devices.
Animal models are critical for assessing how a device interacts with living tissues and how it performs in real-world biological conditions. This article explains how animal models support device testing, how they meet medical device regulations, and why they are essential for ensuring safety and performance in the long term.
HuaTeng provides an overview of how to select the appropriate animal model at each stage of the drug development process, what factors to consider, and why specific models are more effective in certain applications.If you're unsure which animal model to choose, need guidance on designing IND-enabling studies, or want tips on accelerating clinical development, our expert scientists at HuaTeng are here to help.
In biomedical research, selecting the right model is a fundamental aspect of scientific research and can be the key to a successful study, whether for pharmaceuticals or medical devices. This article will walk you through the most common types of animal models, their ideal use cases, and essential factors to consider when choosing the right model for your research, helping you improve both reproducibility and translational success.
HuaTeng explore the role of CDX and syngeneic tumor models in preclinical cancer research. Learn how xenograft models using immunodeficient mice help evaluate chemotherapy and targeted therapies, while syngeneic models in immunocompetent mice support immuno-oncology discovery. Accelerate your drug development pipeline with validated in vivo platforms.
HuaTeng Biotechnology offers rigorously validated Acute Lung Injury (ALI) animal models for ARDS research. Featuring LPS/HCl/mechanical induction, 90% pathological recurrence, and end-to-end services from modeling to cytokine analysis.
HuaTeng Biotechnology maintains a specialized large-animal gene editing platform, utilizing CRISPR/Cas9, TALEN, and ZFN technologies for precision porcie disease model development.
We can provide pre - clinical testing services, covering the entire life cycle of the innovation stage and product development.
At HuaTeng Biotechnology, our In Vitro Platform empowers researchers with cutting-edge cell-based technologies to streamline drug discovery, biomarker validation, and therapeutic development. From primary cell isolation to advanced gene editing, our GLP-compliant workflows deliver reliable, reproducible data to advance your projects from bench to bedside.
At HuaTeng Biotechnology, our Behavioral Neuroscience Platform offers comprehensive, standardized testing to evaluate rodent behavior across motor, cognitive, emotional, and social domains. Utilizing validated paradigms and automated tracking systems, we deliver precise, reproducible data for preclinical studies in CNS drug development, neuropsychiatric research, and neurodegenerative disease modeling.
At HuaTeng Biotechnology, our Molecular Biology Testing Platform delivers end-to-end solutions for nucleic acid, protein, and biomarker analysis. Leveraging cutting-edge technologies and GLP-compliant workflows, we provide pharmaceutical, biotech, and academic partners with reliable, high-throughput data to advance drug discovery, diagnostic development, and translational research.
At HuaTeng Biotechnology, our Quantitative Analysis Platform delivers end-to-end solutions for preclinical drug development, combining cutting-edge technologies with GLP-compliant workflows. We provide pharmaceutical, biotech, and academic partners with high-sensitivity, reproducible data to support pharmacokinetic (PK), pharmacodynamic (PD), and toxicology studies, ensuring robust insights from lead optimization to regulatory submissions.